BIO Announces Speakers for 2007 World Congress on Industrial Biotechnology and Bioprocessing

  • Contact: Contact Paul Winters
    202-962-9237
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (February 1, 2007) – The Biotechnology Industry Organization (BIO) today announced the keynote speakers for the World Congress on Industrial Biotechnology and Bioprocessing. Plenary speakers will examine both the next-generation scientific breakthroughs and the public-private investment policies needed to make large-scale production of biofuels a reality in the United States.

Venture capitalist Vinod Khosla and Assistant Secretary for Energy Efficiency and Renewable Energy Andy Karsner will address the opening lunch plenary session on Thursday March 22. Khosla is the head of Khosla Ventures, a company that actively invests in breakthrough scientific work in clean technology areas such as biorefineries for energy and bioplastics, solar, and other environmentally friendly technologies. Fortune magazine recently called Khosla one of the nation’s most influential ethanol advocates.

Karsner manages the Department of Energy’s $1.17 billion program to promote the development and marketplace integration of renewable and environmentally sound energy technologies and the preservation and efficient use of our nation’s other valuable resources.

Dr. Jay Keasling will address the lunch plenary session on Friday, March 23. Keasling’s work in synthetic biology recently earned him the title of Discover magazine’s 2006 Scientist of the Year. As director of the Berkeley Center for Synthetic Biology, Keasling’s research seeks to expand the biotechnology process from expressing single proteins within cells to recreating complex chemical processes within engineered organisms. Keasling engineered a yeast into a chemical factory to produce a precursor to artemisinin, the most effective and expensive anti-malarial drug. Since artemisinin is a hydrocarbon, this work has led him into study of the production of biofuels.

The Congress, to be held March 21-24, 2007 at the Walt Disney World Swan and Dolphin Resort in Orlando, Fla., is hosted by BIO, the American Chemical Society, the National Agricultural Biotechnology Council, the European Federation of Biotechnology, BIOTECanada and EuropaBIO.

Advance media registration for the 2007 World Congress on Industrial Biotechnology and Bioprocessing is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit http://www.bio.org/worldcongress/media/. Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by 5:00 p.m. ET Thursday, March 15, 2007.

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.

BIO CEO & Investor Conference
Feb. 12-14, 2007, New York City

2007 World Congress on Industrial Biotechnology and Bioprocessing
March 21-24, 2007, Orlando, Fla.

BIO International Convention
May 6-9, 2007, Boston

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.